Delivery Order 75N92020D00022-75N93022F00028

This is a firm fixed price delivery order awarded by the Department of Health and Human Services Food and Drug Administration to Illumina, Inc., a for-profit manufacturer of sequencing and array-based analytical instruments and reagents. The $130,354.54 contract is for the provision of REAGENT (CHEMISTRY) KITS with a completion date of September 14, 2022. Illumina is a well-established provider of genomic sequencing solutions to various federal agencies, including the National Institutes of...

This is a firm fixed price delivery order awarded by the Food and Drug Administration (FDA), a civilian agency, to Illumina, Inc., a for-profit manufacturer of sequencing and genomic analysis instruments and reagents. The contract, valued at $277,984.22, is for the provision of REAGENT (CHEMISTRY) KITS with a period of performance through September 30, 2022. There is no set-aside designation noted. Based on Illumina's background as a provider of genomic sequencing systems and consumables to...

The Environmental Protection Agency (EPA) Office of Research and Development awarded a firm fixed price purchase order to Illumina, Inc. for the supply of NovaSeq 6000 and NextSeq reagent kits. The contract has a potential value of $52,482.40 and a completion date of March 15, 2024. The contract does not have a set-aside designation. Illumina, a for-profit manufacturer of genomic analysis instruments and reagents, has previously provided similar sequencing products and services to support...

This is a firm fixed price delivery order awarded by the Department of Health and Human Services National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases to Illumina, Inc., a for-profit organization and manufacturer of goods. The contract is for the provision of NextSeq Sequencing 500/550 High Output Reagent Kits and NovaSeq 6000 SP and S1 Reagent Kits. The total potential value of the contract is $247,444.82 and the completion date is September 2,...

The Department of Agriculture's Agricultural Research Service Field Research Implementation and Information Delivery Plains Area awarded a $23,921 firm fixed price delivery order to Illumina, Inc. to provide NextSeq 2000 P3 reagents for 300 cycles of sequencing and dual indexing support. The reagents will allow for up to 1.1 billion single reads and include a NextSeq 2000 reagent cartridge for 300 cycles, a NextSeq 2000 P3 flow cell, and RSB W. The products will be delivered to a location in...

This is a firm fixed price delivery order awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to Illumina, Inc. for the purchase of NOVASEQ 6000 S4 REAGENT KIT. The total potential value of the award is $18,519.12. Illumina is a manufacturer of sequencing and array-based solutions for genetic and genomic analysis, and has previously provided a range of sequencing systems, reagents, and services to federal...

This is a firm fixed price delivery order awarded by the Department of Health and Human Services' National Institutes of Health National Cancer Institute to Illumina, Inc. for the procurement of 6 units of the NovaSeq 6000 S4 Reagent Kits (200 cycles). The total potential value of the award is $111,114.72. Illumina, Inc. is a for-profit manufacturer of sequencing and array-based genomic analysis solutions. The company has previously received other federal contracts and subcontracts from agencies...

The Department of Health and Human Services National Institutes of Health (NIH) Clinical Center awarded a $156,650.78 firm fixed price purchase order to Illumina, Inc., a for-profit manufacturer, for the provision of various sequencing reagents and kits to support the NIH's Center for Cellular Engineering (CCE). This includes NextSeq 500/550 v2.5 sequencing reagent kits, PhiX Control v3 kits, and related technical support. The contract has no set-aside designation and is being issued under...

The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents, in the amount of $132,219.06. The award is for the provision of reagent kits, with no set-aside designation. This award is associated with a special notice for NovaSeq reagent kits, which Illumina is the sole manufacturer of. Illumina has a history of providing sequencing systems,...

This is a firm fixed price delivery order awarded by the National Institute on Deafness and Other Communication Disorders (NIDCD), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc. for the purchase of Illumina NextSeq 2000 P4 XLEAP-SBS Reagent Kits (100 cycles). The $10,962 contract is in support of sequencing efforts carried out by the NIDCD's Genomics and Computational Biology Core (GCBC) and has a period of performance through September 2, 2025. No...